The role of glia in retinal vascular disease

REFERENCES

• Good WV, Hardy RJ, Dobsob V, Palmer EA, Phelps DL, Quintos M, Tung B et al. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 2005; 116: 15–23.
   PubMed Web of Science ®Google Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care 2004; 27: 1047–1053.
   PubMed Web of Science ®Google Scholar
• Fong DS, Aiello LP, Ferris FL, Klein R. Diabetic retinopathy. Diabetes Care 2004; 27: 2540–2553.
   PubMed Web of Science ®Google Scholar
• Smith W, Assink J, Klein R, Mitchell P, Klaver CCW, Klein BEK, Hofman A et al. Risk factors for age‐related macular degeneration: pooled findings from three continents. Ophthalmology 2001; 108: 697–704.
   PubMed Web of Science ®Google Scholar
• Yu D‐Y, Cringle SJ. Retinal degeneration and local oxygen metabolism. Exp Eye Res 2005; 80: 745–751.
   PubMed Web of Science ®Google Scholar
• Kaur C, Foulds WS, Ling EA. Blood–retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res 2008; 27: 622–647.
   PubMed Web of Science ®Google Scholar
• Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286: C1213–C1228.
   PubMed Web of Science ®Google Scholar
• Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006; 86: 279–367.
   PubMed Web of Science ®Google Scholar
• Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 2010; 72: 463–493.
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Romero IA. Transporting therapeutics across the blood‐brain barrier. Mol Med Today 1996; 2: 106–113.
   PubMedGoogle Scholar
• Gardner TW, Antonetti DA, Barber AJ, Lanoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Opthalmol 2002; 47 (Suppl 2): S253–S262.
   Google Scholar
• Tang J, Kern TS. Inflammation in diabetic retinopathy. Prog Retin Eye Res 2011; 30: 343–358.
   PubMed Web of Science ®Google Scholar
• Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Opthalmol 1998; 43: 245–269.
   PubMed Web of Science ®Google Scholar
• Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME. Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008; 27: 331–371.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011; 473: 298–307.
   PubMed Web of Science ®Google Scholar
• Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–447.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007; 6: 273–286.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF‐receptor chimeric proteins. Proc Natl Acad Sci USA 1995; 92: 10457–10461.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480–1487.
   PubMed Web of Science ®Google Scholar
• Senger D, Galli S, Dvorak A, Perruzzi C, Harvey V, Dvorak H. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983–985.
   PubMed Web of Science ®Google Scholar
• Ferris FL. How effective are treatments for diabetic retinopathy? JAMA 1993; 269: 1290–1291.
   PubMed Web of Science ®Google Scholar
• Elman MJ, Bressler NM, Qin H, Beck RW, Ferris FL 3rd, Friedman SM, Glassman AR et al. Expanded 2‐year follow‐up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2011; 118: 609–614.
   PubMed Web of Science ®Google Scholar
• Gillies MC, Sutter FKP, Simpson JM, Larsson J, Ali H, Zhu M. Intravitreal triamcinolone for refractory diabetic macular edema: two‐year results of a double‐masked, placebo‐controlled, randomized clinical trial. Ophthalmology 2006; 113: 1533–1538.
   PubMed Web of Science ®Google Scholar
• Michels RG. Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol 1978; 96: 237–246.
   PubMedGoogle Scholar
• Ferris FL, Davis MD, Aiello LM. Treatment of diabetic retinopathy. N Engl J Med 1999; 341: 667–678.
   PubMed Web of Science ®Google Scholar
• Jager RD, Mieler WF, Miller JW. Age‐related macular degeneration. N Engl J Med 2008; 358: 2606–2617.
   PubMed Web of Science ®Google Scholar
• Gardner TW, Abcouwer SF, Barber AJ, Jackson GR. An integrated approach to diabetic retinopathy research. Arch Ophthalmol 2011; 129: 230–235.
   Google Scholar
• Chen J, Smith L. Retinopathy of prematurity. Angiogenesis 2007; 10: 133–140.
   PubMedGoogle Scholar
• Klein R, Klein BEK. Diabetic eye disease. Lancet 1997; 350: 197–204.
   PubMed Web of Science ®Google Scholar
• Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN et al. Müller cells in the healthy and diseased retina. Prog Retin Eye Res 2006; 25: 397–424.
   PubMed Web of Science ®Google Scholar
• Schnitzer J. Astrocytes in the guinea pig, horse, and monkey retina: their occurrence coincides with the presence of blood vessels. Glia 1988; 1: 74–89.
   Web of Science ®Google Scholar
• Karlstetter M, Ebert S, Langmann T. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology 2011; 215: 685–691.
   Web of Science ®Google Scholar
• Bacaj T, Tevlin M, Lu Y, Shaham S. Glia are essential for sensory organ function in C. elegans. Science 2008; 322: 744–747.
   Web of Science ®Google Scholar
• Dubois‐dauphin M, Poitry‐yamate C, De bilbao F, Julliard AK, Jourdan F, Donati G. Early postnatal Müller cell death leads to retinal but not optic nerve degeneration in NSE‐Hu‐Bcl‐2 transgenic mice. Neuroscience 1999; 95: 9–21.
   Web of Science ®Google Scholar
• Reichenbach A, Fuchs U, Kasper M, El‐hifnawi E, Eckstein A. Hepatic retinopathy: morphological features of retinal glial (Müller) cells accompanying hepatic failure. Acta Neuropathol 1995; 90: 273–281.
   Web of Science ®Google Scholar
• Kellner U, Kraus H, Heimann H, Helbig H, Bornfeld N, Foerster MH. Electrophysiological evaluation of visual loss in Müller cell sheen dystrophy. Br J Ophthalmol 1998; 82: 650–654.
   Web of Science ®Google Scholar
• Powner MB, Gillies MC, Tretiach M, Scott A, Guymer RH, Hageman GS, Fruttiger M. Perifoveal Müller cell depletion in a case of macular telangiectasia type 2. Ophthalmology 2010; 117: 2407–2416.
   PubMed Web of Science ®Google Scholar
• Peek R, Verbraak F, Coevoet HM, Kijlstra A. Müller cell‐specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci 1998; 39: 1976–1979.
   PubMed Web of Science ®Google Scholar
• Bringmann A, Pannicke T, Biedermann B, Francke M, Iandiev I, Grosche J, Wiedemann P et al. Role of retinal glial cells in neurotransmitter uptake and metabolism. Neurochem Int 2009; 54: 143–160.
   PubMed Web of Science ®Google Scholar
• Ames A. CNS energy metabolism as related to function. Brain Res Brain Res Rev 2000; 34: 42–68.
   PubMed Web of Science ®Google Scholar
• Ames A, Li Y, Heher E, Kimble C. Energy metabolism of rabbit retina as related to function: high cost of Na+ transport. J Neurosci 1992; 12: 840–853.
   PubMed Web of Science ®Google Scholar
• Tsacopoulos M, Magistretti P. Metabolic coupling between glia and neurons. J Neurosci 1996; 16: 877–885.
   PubMed Web of Science ®Google Scholar
• Poitry‐yamate C, Poitry S, Tsacopoulos M. Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina. J Neurosci 1995; 15: 5179–5191.
   PubMed Web of Science ®Google Scholar
• Winkler BS, Arnold MJ, Brassell MA, Puro DG. Energy metabolism in human retinal Müller cells. Invest Ophthalmol Vis Sci 2000; 41: 3183–3190.
   PubMed Web of Science ®Google Scholar
• Kuwabara T, Cogan DG. Retinal glycogen. Arch Ophthalmol 1961; 66: 680–688.
   PubMedGoogle Scholar
• Peterson WM, Wang Q, Tzekova R, Wiegand SJ. Ciliary neurotrophic factor and stress stimuli activate the Jak‐STAT pathway in retinal neurons and glia. J Neurosci 2000; 20: 4081–4090.
   PubMed Web of Science ®Google Scholar
• Wahlin KJ, Campochiaro PA, Zack DJ, Adler R. Neurotrophic factors cause activation of intracellular signaling pathways in Müller cells and other cells of the inner retina but not photoreceptors. Invest Ophthalmol Vis Sci 2000; 41: 927–936.
   PubMed Web of Science ®Google Scholar
• Joly S, Lange C, Thiersch M, Samardzija M, Grimm C. Leukemia inhibitory factor extends the lifespan of injured photoreceptors in vivo. J Neurosci 2008; 28: 13765–13774.
   PubMed Web of Science ®Google Scholar
• Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, Wiedemann P, Osborne NN, Reichenbach A. Cellular signaling and factors involved in Müller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 2009; 28: 423–451.
   PubMed Web of Science ®Google Scholar
• Walsh N, Valter K, Stone J. Cellular and subcellular patterns of expression of bFGF and CNTF in the normal and light stressed adult rat retina. Exp Eye Res 2001; 72: 495–501.
   Web of Science ®Google Scholar
• Wen R, Cheng T, Li Y, Cao W, Steinberg RH. α2‐adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage. J Neurosci 1996; 16: 5986–5992.
   PubMed Web of Science ®Google Scholar
• Wassle H. Parallel processing in the mammalian retina. Nat Rev Neurosci 2004; 5: 747–757.
   PubMed Web of Science ®Google Scholar
• Thoreson WB, Witkovsky P. Glutamate receptors and circuits in the vertebrate retina. Prog Retin Eye Res 1999; 18: 765–810.
   Web of Science ®Google Scholar
• Beart PM, O'shea RD. Transporters for L‐glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 2007; 150: 5–17.
   Web of Science ®Google Scholar
• Riepe RE, Norenburg MD. Müller cell localisation of glutamine synthetase in rat retina. Nature 1977; 268: 654–655.
   PubMed Web of Science ®Google Scholar
• Barnett NL, Pow DV, Robinson SR. Inhibition of Müller cell glutamine synthetase rapidly impairs the retinal response to light. Glia 2000; 30: 64–73.
   PubMed Web of Science ®Google Scholar
• Poitry S, Poitry‐yamate C, Ueberfeld J, Macleish PR, Tsacopoulos M. Mechanisms of glutamate metabolic signaling in retinal glial (Müller) cells. J Neurosci 2000; 20: 1809–1821.
   Web of Science ®Google Scholar
• Szatkowski M, Barbour B, Attwell D. Non‐vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 1990; 348: 443–446.
   PubMed Web of Science ®Google Scholar
• Newman E. Inward‐rectifying potassium channels in retinal glial (Müller) cells. J Neurosci 1993; 13: 3333–3345.
   PubMed Web of Science ®Google Scholar
• Newman E, Frambach D, Odette L. Control of extracellular potassium levels by retinal glial cell K+ siphoning. Science 1984; 225: 1174–1175.
   PubMed Web of Science ®Google Scholar
• Nagelhus EA, Horio Y, Inanobe A, Fujita A, Haug FM, Nielsen S, Kurachi Y et al. Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Müller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains. Glia 1999; 26: 47–54.
   PubMed Web of Science ®Google Scholar
• Verkman AS. Role of aquaporin water channels in eye function. Exp Eye Res 2003; 76: 137–143.
   PubMed Web of Science ®Google Scholar
• Bouvier M, Szatkowski M, Amato A, Attwell D. The glial cell glutamate uptake carrier countertransports pH‐changing anions. Nature 1992; 360: 471–474.
   PubMed Web of Science ®Google Scholar
• Nicholson C, Syková E. Extracellular space structure revealed by diffusion analysis. Trends Neurosci 1998; 21: 207–215.
   PubMed Web of Science ®Google Scholar
• Abbott NJ, Ronnback L, Hansson E. Astrocyte‐endothelial interactions at the blood‐brain barrier. Nat Rev Neurosci 2006; 7: 41–53.
   PubMed Web of Science ®Google Scholar
• Haydon PG. Glia: listening and talking to the synapse. Nat Rev Neurosci 2001; 2: 185–193.
   PubMed Web of Science ®Google Scholar
• Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: glia, the unacknowledged partner. Trends Neurosci 1999; 22: 208–215.
   PubMed Web of Science ®Google Scholar
• Stone J, Dreher Z. Relationship between astrocytes, ganglion cells and vasculature of the retina. J Comp Neurol 1987; 255: 35–49.
   PubMed Web of Science ®Google Scholar
• Holländer H, Makarov F, Dreher Z, Van driel D, Chan‐ling T, Stone J. Structure of the macroglia of the retina: sharing and division of labour between astrocytes and Müller cells. J Comp Neurol 1991; 313: 587–603.
   Web of Science ®Google Scholar
• Zahs KR, Newman EA. Asymmetric gap junctional coupling between glial cells in the rat retina. Glia 1997; 20: 10–22.
   Web of Science ®Google Scholar
• Newman EA, Zahs KR. Calcium waves in retinal glial cells. Science 1997; 275: 844–847.
   PubMed Web of Science ®Google Scholar
• Oliet SHR, Piet R, Poulain DA. Control of glutamate clearance and synaptic efficacy by glial coverage of neurons. Science 2001; 292: 923–926.
   PubMed Web of Science ®Google Scholar
• Franze K, Grosche J, Skatchkov SN, Schinkinger S, Foja C, Schild D, Uckermann O et al. Müller cells are living optical fibers in the vertebrate retina. Proc Natl Acad Sci USA 2007; 104: 8287–8292.
   Web of Science ®Google Scholar
• Hume DA, Perry VH, Gordon S. Immunohistochemical localization of a macrophage‐specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 1983; 97: 253–257.
   PubMed Web of Science ®Google Scholar
• Frade JM, Barde Y‐A. Microglia‐derived nerve growth factor causes cell death in the developing retina. Neuron 1998; 20: 35–41.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005; 308: 1314–1318.
   PubMed Web of Science ®Google Scholar
• Lee JE, Liang KJ, Fariss RN, Wong WT. Ex vivo dynamic imaging of retinal microglia using time‐lapse confocal microscopy. Invest Ophthalmol Vis Sci 2008; 49: 4169–4176.
   Web of Science ®Google Scholar
• Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol 2007; 81: 1345–1351.
   PubMed Web of Science ®Google Scholar
• Santos AM, Martín‐oliva D, Ferrer‐martín RM, Tassi M, Calvente R, Sierra A, Carrasco M‐C et al. Microglial response to light‐induced photoreceptor degeneration in the mouse retina. J Comp Neurol 2010; 518: 477–492.
   PubMed Web of Science ®Google Scholar
• Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, Zurawski SM, Blom B, et al. Down‐regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000; 290: 1768–1771.
   PubMed Web of Science ®Google Scholar
• Hanisch U‐K. Microglia as a source and target of cytokines. Glia 2002; 40: 140–155.
   PubMed Web of Science ®Google Scholar
• Hanisch U‐K, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007; 10: 1387–1394.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Raff MC. Retinal astrocytes are immigrants from the optic nerve. Nature 1988; 332: 834–837.
   Web of Science ®Google Scholar
• Fruttiger M. Development of the retinal vasculature. Angiogenesis 2007; 10: 77–88.
   PubMedGoogle Scholar
• Mudhar HS, Pollock RA, Wang C, Stiles CD, Richardson WD. PDGF and its receptors in the developing rodent retina and optic nerve. Development 1993; 118: 539–552.
   PubMed Web of Science ®Google Scholar
• Fruttiger M, Calver AR, Richardson WD. Platelet‐derived growth factor is constitutively secreted from neuronal cell bodies but not from axons. Curr Biol 2000; 10: 1283–1286.
   PubMed Web of Science ®Google Scholar
• Fruttiger M, Calver AR, Krüger WH, Mudhar HS, Michalovich D, Takakura N, Nishikawa SI et al. PDGF mediates a neuron–astrocyte interaction in the developing retina. Neuron 1996; 17: 1117–1131.
   PubMed Web of Science ®Google Scholar
• Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R‐cadherin adhesion. Invest Ophthalmol Vis Sci 2002; 43: 3500–3510.
   PubMed Web of Science ®Google Scholar
• Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan‐ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia‐induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995; 15: 4738–4747.
   PubMed Web of Science ®Google Scholar
• Ye X, Wang Y, Nathans J. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol Med 2010; 16: 417–425.
   PubMed Web of Science ®Google Scholar
• Checchin D, Sennlaub F, Levavasseur E, Leduc M, Chemtob S. Potential role of microglia in retinal blood vessel formation. Invest Ophthalmol Vis Sci 2006; 47: 3595–3602.
   PubMed Web of Science ®Google Scholar
• Gardner TW, Lieth E, Khin SA, Barber AJ, Bonsall DJ, Lesher T, Rice K et al. Astrocytes increase barrier properties and ZO‐1 expression in retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 1997; 38: 2423–2427.
   PubMed Web of Science ®Google Scholar
• Shen W, Li S, Chung SH, Gillies MC. Retinal vascular changes after glial disruption in rats. J Neurosci Res 2010; 88: 1485–1499.
   PubMed Web of Science ®Google Scholar
• Lewis GP, Fisher SK. Up‐regulation of glial fibrillary acidic protein in response to retinal injury: its potential role in glial remodeling and a comparison to vimentin expression. Int Rev Cytol 2003; 230: 263–290.
   PubMed Web of Science ®Google Scholar
• Grosche J, Härtig W, Reichenbach A. Expression of glial fibrillary acidic protein (GFAP), glutamine synthetase (GS), and Bcl‐2 protooncogene protein by Müller (glial) cells in retinal light damage of rats. Neurosci Lett 1995; 185: 119–122.
   PubMed Web of Science ®Google Scholar
• Lewis GP, Erickson PA, Guerin CJ, Anderson DH, Fisher SK. Changes in the expression of specific Müller cell proteins during long‐term retinal detachment. Exp Eye Res 1989; 49: 93–111.
   PubMed Web of Science ®Google Scholar
• Marc RE, Murry RF, Fisher SK, Linberg KA, Lewis GP. Amino acid signatures in the detached cat retina. Invest Ophthalmol Vis Sci 1998; 39: 1694–1702.
   PubMed Web of Science ®Google Scholar
• Ekström P, Sanyal S, Narfström K, Chader GJ, Van veen T. Accumulation of glial fibrillary acidic protein in Müller radial glia during retinal degeneration. Invest Ophthalmol Vis Sci 1988; 29: 1363–1371.
   PubMed Web of Science ®Google Scholar
• Sarthy PV, Fu M. Transcriptional activation of an intermediate filament protein gene in mice with retinal dystrophy. DNA 1989; 8: 437–446.
   PubMedGoogle Scholar
• Lu Y‐B, Iandiev I, Hollborn M, Körber N, Ulbricht E, Hirrlinger PG, Pannicke T et al. Reactive glial cells: increased stiffness correlates with increased intermediate filament expression. FASEB J 2011; 25: 624–631.
   PubMed Web of Science ®Google Scholar
• Lu Y‐B, Franze K, Seifert G, Steinhäuser C, Kirchhoff F, Wolburg H, Guck J et al. Viscoelastic properties of individual glial cells and neurons in the CNS. Proc Natl Acad Sci USA 2006; 103: 17759–17764.
   PubMed Web of Science ®Google Scholar
• Lundkvist A, Reichenbach A, Betsholtz C, Carmeliet P, Wolburg H, Pekny M. Under stress, the absence of intermediate filaments from Müller cells in the retina has structural and functional consequences. J Cell Sci 2004; 117: 3481–3488.
   Web of Science ®Google Scholar
• Harada T, Harada C, Kohsaka S, Wada E, Yoshida K, Ohno S, Mamada H et al. Microglia–Müller glia cell interactions control neurotrophic factor production during light‐induced retinal degeneration. J Neurosci 2002; 22: 9228–9236.
   PubMed Web of Science ®Google Scholar
• Maharaj ASR, Saint‐geniez M, Maldonado AE, D'amore PA. Vascular endothelial growth factor localization in the adult. Am J Pathol 2006; 168: 639–648.
   PubMed Web of Science ®Google Scholar
• Storkebaum E, Lambrechts D, Dewerchin M, Moreno‐murciano M‐P, Appelmans S, Oh H, Van damme P et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 2005; 8: 85–92.
   PubMed Web of Science ®Google Scholar
• Sun F‐Y, Guo X. Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 2005; 79: 180–184.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A et al. Monocyte chemoattractant protein 1 mediates retinal detachment‐induced photoreceptor apoptosis. Proc Natl Acad Sci USA 2007; 104: 2425–2430.
   PubMed Web of Science ®Google Scholar
• Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D, Miyahara S et al. Characterization of cytokine responses to retinal detachment in rats. Mol Vis 2006; 12: 867–878.
   PubMed Web of Science ®Google Scholar
• Roque RS, Rosales AA, Jingjing L, Agarwal N, Al‐ubaidi MR. Retina‐derived microglial cells induce photoreceptor cell death in vitro. Brain Res 1999; 836: 110–119.
   PubMed Web of Science ®Google Scholar
• Srinivasan B, Roque CH, Hempstead BL, Al‐ubaidi MR, Roque RS. Microglia‐derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem 2004; 279: 41839–41845.
   Web of Science ®Google Scholar
• Dyer MA, Cepko CL. Control of Müller glial cell proliferation and activation following retinal injury. Nat Neurosci 2000; 3: 873–880.
   PubMed Web of Science ®Google Scholar
• Burke JM, Smith JM. Retinal proliferation in response to vitreous hemoglobin or iron. Invest Ophthalmol Vis Sci 1981; 20: 582–592.
   PubMed Web of Science ®Google Scholar
• Jones BW, Watt CB, Frederick JM, Baehr W, Chen C‐K, Levine EM, Milam AH et al. Retinal remodeling triggered by photoreceptor degenerations. J Comp Neurol 2003; 464: 1–16.
   PubMed Web of Science ®Google Scholar
• Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res 2003; 22: 607–655.
   PubMed Web of Science ®Google Scholar
• O'connor AR, Stephenson T, Johnson A, Tobin MJ, Moseley MJ, Ratib S, Ng Y et al. Long‐term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity. Pediatrics 2002; 109: 12–18.
   PubMed Web of Science ®Google Scholar
• Fulton AB, Hansen RM, Moskowitz A, Akula JD. The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res 2009; 28: 452–482.
   PubMed Web of Science ®Google Scholar
• Smith LE, Wesolowski E, Mclellan A, Kostyk SK, D'amato R, Sullivan R, D'amore PA. Oxygen‐induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994; 35: 101–111.
   PubMed Web of Science ®Google Scholar
• Fulton AB, Hansen RM, Petersen RA, Vanderveen DK. The rod photoreceptors in retinopathy of prematurity: an electroretinographic study. Arch Ophthalmol 2001; 119: 499–505.
   Google Scholar
• Fulton AB, Hansen RM, Moskowitz A. The cone electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci 2008; 49: 814–819.
   Web of Science ®Google Scholar
• Akula JD, Hansen RM, Martinez‐perez ME, Fulton AB. Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest Ophthalmol Vis Sci 2007; 48: 4351–4359.
   Web of Science ®Google Scholar
• Liu K, Akula JD, Falk C, Hansen RM, Fulton AB. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2006; 47: 2639–2647.
   Web of Science ®Google Scholar
• Downie LE, Hatzopoulos KM, Pianta MJ, Vingrys AJ, Wilkinson‐berka JL, Kalloniatis M, Fletcher EL. Angiotensin type‐1 receptor inhibition is neuroprotective to amacrine cells in a rat model of retinopathy of prematurity. J Comp Neurol 2010; 518: 41–63.
   Web of Science ®Google Scholar
• Fulton AB, Reynaud X, Hansen RM, Lemere CA, Parker C, Williams TP. Rod photoreceptors in infant rats with a history of oxygen exposure. Invest Ophthalmol Vis Sci 1999; 40: 168–174.
   PubMed Web of Science ®Google Scholar
• Downie LE, Pianta MJ, Vingrys AJ, Wilkinson‐berka JL, Fletcher EL. Neuronal and glial cell changes are determined by retinal vascularization in retinopathy of prematurity. J Comp Neurol 2007; 504: 404–417.
   PubMed Web of Science ®Google Scholar
• Chan‐ling T, Stone J. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood‐retinal barrier. Invest Ophthalmol Vis Sci 1992; 33: 2148–2159.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Stone J. Role of astrocytes in the control of developing retinal vessels. Invest Ophthalmol Vis Sci 1997; 38: 1653–1666.
   PubMed Web of Science ®Google Scholar
• Downie LE, Pianta MJ, Vingrys AJ, Wilkinson‐berka JL, Fletcher EL. AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen‐induced retinopathy. Glia 2008; 56: 1076–1090.
   Web of Science ®Google Scholar
• Chan‐ling T, Gock B, Stone J. The effect of oxygen on vasoformative cell division. Evidence that ‘physiological hypoxia’ is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci 1995; 36: 1201–1214.
   PubMed Web of Science ®Google Scholar
• Chan‐ling T, Stone J. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood‐retinal barrier. Invest Ophthalmol Vis Sci 1992; 33: 2148–2159.
   PubMed Web of Science ®Google Scholar
• Chan‐ling T, Tout S, Holländer H, Stone J. Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1992; 33: 2128–2147.
   PubMed Web of Science ®Google Scholar
• Stone J, Chan‐ling T, Pe'er J, Itin A, Gnessin H, Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1996; 37: 290–299.
   PubMed Web of Science ®Google Scholar
• Dorrell MI, Aguilar E, Jacobson R, Trauger SA, Friedlander J, Siuzdak G, Friedlander M. Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen‐induced retinopathy. Glia 2010; 58: 43–54.
   Web of Science ®Google Scholar
• Tout S, Chan‐ling T, Holländer H, Stone J. The role of Müller cells in the formation of the blood‐retinal barrier. Neuroscience 1993; 55: 291–301.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ma W, Fariss RN, Wong WT. Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy. Exp Eye Res 2009; 88: 1004–1013.
   Web of Science ®Google Scholar
• Vessey KA, Wilkinson‐berka JL, Fletcher EL. Characterization of retinal function and glial cell response in a mouse model of oxygen‐induced retinopathy. J Comp Neurol 2011; 519: 506–527.
   Web of Science ®Google Scholar
• Ritter MR, Banin E, Moreno SK, Aguilar E, Dorrell MI, Friedlander M. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest 2006; 116: 3266–3276.
   PubMed Web of Science ®Google Scholar
• Moravski CJ, Kelly DJ, Cooper ME, Gilbert RE, Bertram JF, Shahinfar S, Skinner SL et al. Retinal neovascularization is prevented by blockade of the renin‐angiotensin system. Hypertension 2000; 36: 1099–1104.
   PubMed Web of Science ®Google Scholar
• Danser AH, Van den dorpel MA, Deinum J, Derkx FH, Franken AA, Peperkamp E, De jong PT et al. Renin, prorenin and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 1989; 68: 160–167.
   PubMed Web of Science ®Google Scholar
• Danser AH, Derkx FH, Admiraal PJ, Deinum J, De jong PT, Schalekamp MA. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 1994; 35: 1008–1018.
   PubMed Web of Science ®Google Scholar
• Sarlos S, Rizkalla B, Moravski CJ, Cao Z, Cooper ME, Wilkinson‐berka JL. Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin. Am J Pathol 2003; 163: 879–887.
   PubMed Web of Science ®Google Scholar
• Yokota H, Nagaoka T, Mori F, Hikichi T, Hosokawa H, Tanaka H, Ishida Y et al. Prorenin levels in retinopathy of prematurity. Am J Ophthalmol 2007; 143: 531–533.
   Web of Science ®Google Scholar
• Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, Ozawa Y et al. Role of non‐proteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci 2007; 48: 422–429.
   PubMed Web of Science ®Google Scholar
• Nagai N, Noda K, Urano T, Kubota Y, Shinoda H, Koto T, Shinoda K et al. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci 2005; 46: 1078–1084.
   PubMed Web of Science ®Google Scholar
• Hard A‐L, Wennerholm U‐B, Niklasson A, Hellstrom A. Severe ROP in twins after blockage of the renin‐angiotensin system during gestation. Acta Paediatr 2008; 97: 1142–1144.
   Web of Science ®Google Scholar
• Ohlmann A, Seitz R, Braunger B, Seitz D, Bösl MR, Tamm ER. Norrin promotes vascular regrowth after oxygen‐induced retinal vessel loss and suppresses retinopathy in mice. J Neurosci 2010; 30: 183–193.
   Web of Science ®Google Scholar
• Ewing FME, Deary IJ, Strachan MWJ, Frier BM. Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev 1998; 19: 462–476.
   PubMed Web of Science ®Google Scholar
• Holfort SK, Klemp K, Kofoed PK, Sander B, Larsen M. Scotopic electrophysiology of the retina during transient hyperglycemia in type 2 diabetes. Invest Ophthalmol Vis Sci 2010; 51: 2790–2794.
   Web of Science ®Google Scholar
• Palmowski AM, Sutter EE, Bearse MA Jr, Fung W. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci 1997; 38: 2586–2596.
   PubMed Web of Science ®Google Scholar
• Bresnick GH, Palta M. Predicting progression to severe proliferative diabetic retinopathy. Arch Ophthalmol 1987; 105: 810–814.
   PubMedGoogle Scholar
• Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM. Glial reactivity and impaired glutamate metabolism in short‐term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 1998; 47: 815–820.
   PubMed Web of Science ®Google Scholar
• Rungger‐brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 2000; 41: 1971–1980.
   PubMed Web of Science ®Google Scholar
• Baydas G, Tuzcu M, Yasar A, Baydas B. Early changes in glial reactivity and lipid peroxidation in diabetic rat retina: effects of melatonin. Acta Diabetol 2004; 41: 123–128.
   PubMed Web of Science ®Google Scholar
• Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003; 52: 506–511.
   PubMed Web of Science ®Google Scholar
• Mizutani M, Gerhardinger C, Lorenzi M. Müller cell changes in human diabetic retinopathy. Diabetes 1998; 47: 445–449.
   PubMed Web of Science ®Google Scholar
• Barber AJ, Antonetti DA, Gardner TW, Group TPSRR. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 2000; 41: 3561–3568.
   PubMed Web of Science ®Google Scholar
• Ly A, Yee P, Vessey KA, Phipps JA, Jobling AI, Fletcher EL. Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss. Invest Ophthalmol Vis Sci 2011; 52: 9316–9326
   PubMed Web of Science ®Google Scholar
• Li Q, Puro DG. Diabetes‐induced dysfunction of the glutamate transporter in retinal Müller cells. Invest Ophthalmol Vis Sci 2002; 43: 3109–3116.
   PubMed Web of Science ®Google Scholar
• Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 2011; 52: 1156–1163.
   PubMed Web of Science ®Google Scholar
• Gerhardinger C, Costa MB, Coulombe MC, Toth I, Hoehn T, Grosu P. Expression of acute‐phase response proteins in retinal Müller cells in diabetes. Invest Ophthalmol Vis Sci 2005; 46: 349–357.
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M et al. Diabetic retinopathy: seeing beyond glucose‐induced microvascular disease. Diabetes 2006; 55: 2401–2411.
   PubMed Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004; 18: 1450–1452.
   PubMed Web of Science ®Google Scholar
• Shelton MD, Kern TS, Mieyal JJ. Glutaredoxin regulates nuclear factor kappa‐B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy. J Biol Chem 2007; 282: 12467–12474.
   PubMed Web of Science ®Google Scholar
• Bek T. Immunohistochemical characterization of retinal glial cell changes in areas of vascular occlusion secondary to diabetic retinopathy. Acta Ophthalmol Scand 1997; 75: 388–392.
   PubMedGoogle Scholar
• Bek T. Capillary closure secondary to retinal vein occlusion. A morphological, histopathological, and immunohistochemical study. Acta Ophthalmol Scand 1998; 76: 643–648.
   Google Scholar
• Behzadian MA, Wang XL, Windsor LJ, Ghaly N, Caldwell RB. TGF‐beta increases retinal endothelial cell permeability by increasing MMP‐9: possible role of glial cells in endothelial barrier function. Invest Ophthalmol Vis Sci 2001; 42: 853–859.
   PubMed Web of Science ®Google Scholar
• Jin M, Kashiwagi K, Iizuka Y, Tanaka Y, Imai M, Tsukahara S. Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina 2001; 21: 28–33.
   PubMed Web of Science ®Google Scholar
• Giebel SJ, Menicucci G, Mcguire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood‐retinal barrier. Lab Invest 2005; 85: 597–607.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu X, Elliott MH, Zhu M, Le Y‐Z. Müller cell‐derived VEGF is essential for diabetes‐induced retinal inflammation and vascular leakage. Diabetes 2010; 59: 2297–2305.
   PubMed Web of Science ®Google Scholar
• Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX. Pigment epithelium‐derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 2006; 20: 323–325.
   PubMed Web of Science ®Google Scholar
• Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, Lavail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990; 347: 83–86.
   PubMed Web of Science ®Google Scholar
• Mark RJ, Keller JN, Kruman I, Mattson MP. Basic FGF attenuates amyloid β‐peptide‐induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+‐ATPase activity in hippocampal neurons. Brain Res 1997; 756: 205–214.
   PubMed Web of Science ®Google Scholar
• Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S, Hori S. Vitreous levels of interleukin‐6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 2003; 110: 1690–1696.
   PubMed Web of Science ®Google Scholar
• Malecaze F, Clamens S, Simorre‐pinatel V, Mathis A, Chollet P, Favard C, Bayard F et al. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor‐like activity in proliferative diabetic retinopathy. Arch Ophthalmol 1994; 112: 1476–1482.
   PubMed Web of Science ®Google Scholar
• Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M. Unbalanced vitreous levels of pigment epithelium‐derived growth factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol 2002; 134: 348–353.
   PubMed Web of Science ®Google Scholar
• Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H et al. VEGF‐initiated blood–retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 2001; 42: 2408–2413.
   PubMed Web of Science ®Google Scholar
• Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neovascular age‐related macular degeneration. Ophthalmology 2006; 113: 363–372.
   PubMed Web of Science ®Google Scholar
• Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res 1996; 36: 2979–2994.
   PubMed Web of Science ®Google Scholar
• Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991; 88: 11555–11558.
   PubMed Web of Science ®Google Scholar
• Tezel G, Luo C, Yang X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest Ophthalmol Vis Sci 2007; 48: 1201–1211.
   PubMed Web of Science ®Google Scholar
• Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL et al. The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 2005; 46: 2916–2924.
   PubMed Web of Science ®Google Scholar
• El‐asrar AMA, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K. Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 2001; 132: 551–556.
   Web of Science ®Google Scholar
• El‐asrar AM, Meersschaert A, Dralands L, Missotten L, Geboes K. Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes. Eye 2000; 18: 306–313.
   Google Scholar
• Carmo A, Cunha‐vaz JG, Carvalho AP, Lopes MC. Nitric oxide synthase activity in retinas from non‐insulin‐dependent diabetic Goto‐Kakizaki rats: correlation with blood–retinal barrier permeability. Nitric Oxide 2000; 4: 590–596.
   PubMed Web of Science ®Google Scholar
• Zeng HY, Green WR, Tso MO. Microglial activation in human diabetic retinopathy. Arch Ophthalmol 2008; 126: 227–232.
   PubMedGoogle Scholar
• Zeng XX, Ng YK, Ling EA. Neuronal and microglial response in the retina of streptozotocin‐induced diabetic rats. Vis Neurosci 2000; 17: 463–471.
   PubMed Web of Science ®Google Scholar
• Barber AJ, Antonetti DA, Kern TS, Reiter CEN, Soans RS, Krady JK, Levison SW et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 2005; 46: 2210–2218.
   PubMed Web of Science ®Google Scholar
• Krady JK, Basu A, Allen CM, Xu Y, Lanoue KF, Gardner TW, Levison SW. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase‐3 activation in a rodent model of diabetic retinopathy. Diabetes 2005; 54: 1559–1565.
   PubMed Web of Science ®Google Scholar
• Xu H, Chen M, Manivannan A, Lois N, Forrester JV. Age‐dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell 2008; 7: 58–68.
   PubMed Web of Science ®Google Scholar
• Xu H, Chen M, Forrester JV. Para‐inflammation in the aging retina. Prog Retin Eye Res 2009; 28: 348–368.
   PubMed Web of Science ®Google Scholar
• Jiang LQ, Jorquera M, Streilein JW. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts. Invest Ophthalmol Vis Sci 1993; 34: 3347–3354.
   PubMed Web of Science ®Google Scholar
• Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 2005; 80: 595–606.
   PubMed Web of Science ®Google Scholar
• Ma W, Zhao L, Fontainhas AM, Fariss RN, Wong WT. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS One 2009; 4: e7945.
   Web of Science ®Google Scholar
• Bressler NM, Silva JC, Bressler SB, Fine SL, Green WR. Clinicopathologic correlation of drusen and retinal pigment epithelial abnormalities in age‐related macular degeneration. Retina 1994; 14: 130–142.
   PubMed Web of Science ®Google Scholar
• Green WR. Histopathology of age‐related macular degeneration. Mol Vis 1999; 5: 27.
   PubMed Web of Science ®Google Scholar
• Gao H, Hollyfield JG. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1992; 33: 1–17.
   PubMed Web of Science ®Google Scholar
• Chen H, Liu B, Lukas TJ, Neufeld AH. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age‐related macular degeneration. PLoS One 2008; 3: e2339.
   Web of Science ®Google Scholar
• Chen M, Muckersie E, Robertson M, Forrester JV, Xu H. Up‐regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp Eye Res 2008; 87: 543–550.
   Web of Science ®Google Scholar
• Steinle JJ, Sharma S, Smith CP, Mcfayden‐ketchum LS. Normal aging involves modulation of specific inflammatory markers in the rat retina and choroid. The J Gerontol A Biol Sci Med Sci 2009; 64A: 325–331.
   Google Scholar
• Kelly J, Khan AA, Yin J, Ferguson TA, Apte RS. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest 2007; 117: 3421–3426.
   PubMed Web of Science ®Google Scholar
• Zhao L, Ma W, Fariss RN, Wong WT. Minocycline attenuates photoreceptor degeneration in a mouse model of subretinal hemorrhage: microglial inhibition as a potential therapeutic strategy. Am J Pathol 2011; 179: 1265–1277.
   Web of Science ®Google Scholar
• Combadière C, Feumi C, Raoul W, Keller N, Rodéro M, Pézard A, Lavalette S et al. CX3CR1‐dependent subretinal microglia cell accumulation is associated with cardinal features of age‐related macular degeneration. J Clin Invest 2007; 117: 2920–2928.
   PubMed Web of Science ®Google Scholar
• Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, Kuziel WA, Rollins BJ et al. An animal model of age‐related macular degeneration in senescent Ccl‐2‐ or Ccr‐2‐deficient mice. Nat Med 2003; 9: 1390–1397.
   PubMed Web of Science ®Google Scholar
• Tuo J, Bojanowski CM, Zhou M, Shen D, Ross RJ, Rosenberg KI, Cameron DJ et al. Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age‐related macular degeneration. Invest Ophthalmol Vis Sci 2007; 48: 3827–3836.
   PubMed Web of Science ®Google Scholar
• Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, Luong V, Fitzke FW et al. The drusenlike phenotype in aging Ccl2‐knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 2009; 50: 5934–5943.
   PubMed Web of Science ®Google Scholar
• Joly S, Francke M, Ulbricht E, Beck S, Seeliger M, Hirrlinger P, Hirrlinger J et al. Cooperative phagocytes: resident microglia and bone marrow immigrants remove dead photoreceptors in retinal lesions. Am J Pathol 2009; 174: 2310–2323.
   PubMed Web of Science ®Google Scholar
• Raoul W, Keller N, Rodéro M, Behar‐cohen F, Sennlaub F, Combadière C. Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells. J Neuroimmunol 2008; 198: 56–61.
   PubMed Web of Science ®Google Scholar
• Gu X, Meer SG, Miyagi M, Rayborn ME, Hollyfield JG, Crabb JW, Salomon RG. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age‐related macular degeneration. J Biol Chem 2003; 278: 42027–42035.
   PubMed Web of Science ®Google Scholar
• Gurne DH, Tso MO, Edward DP, Ripps H. Antiretinal antibodies in serum of patients with age‐related macular degeneration. Ophthalmology 1991; 98: 602–607.
   PubMed Web of Science ®Google Scholar
• Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. Autoantibodies to retinal astrocytes associated with age‐related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1990; 228: 270–274.
   PubMed Web of Science ®Google Scholar
• Tuo J, Smith BC, Bojanowski CM, Meleth AD, Gery I, Csaky KG, Chew EY et al. The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age‐related macular degeneration. FASEB J 2004; 19: 1297–1299.
   Google Scholar
• Ramírez JM, Ramírez AI, Salazar JJ, De hoz R, Triviño A. Changes of astrocytes in retinal ageing and age‐related macular degeneration. Exp Eye Res 2001; 73: 601–615.
   Web of Science ®Google Scholar
• Madigan MC, Penfold PL, Provis JM, Balind TK, Billson FA. Intermediate filament expression in human retinal macroglia. Histopathologic changes associated with age‐related macular degeneration. Retina 1994; 14: 65–74.
   PubMed Web of Science ®Google Scholar
• Wu KHC, Madigan MC, Billson FA, Penfold PL. Differential expression of GFAP in early v late AMD: a quantitative analysis. Br J Ophthalmol 2003; 87: 1159–1166.
   PubMed Web of Science ®Google Scholar
• Kimura H, Spee C, Sakamoto T, Hinton DR, Ogura Y, Tabata Y, Ikada Y, Ryan SJ. Cellular response in subretinal neovascularization induced by bFGF‐impregnated microspheres. Invest Ophthalmol Vis Sci 1999; 40: 524–528.
   PubMed Web of Science ®Google Scholar
• Sullivan R, Penfold P, Pow DV. Neuronal migration and glial remodeling in degenerating retinas of aged rats and in nonneovascular AMD. Invest Ophthalmol Vis Sci 2003; 44: 856–865.
   PubMed Web of Science ®Google Scholar
• Charbel issa P, Berendschot TT, Staurenghi G, Holz FG, Scholl HP. Confocal blue reflectance imaging in type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 2008; 49: 1172–1177.
   PubMed Web of Science ®Google Scholar
• Charbel issa P, Van der veen RL, Stijfs A, Holz FG, Scholl HP, Berendschot TT. Quantification of reduced macular pigment optical density in the central retina in macular telangiectasia type 2. Exp Eye Res 2009; 89: 25–31.
   PubMed Web of Science ®Google Scholar
• Helb HM, Charbel issa P, Van der veen RL, Berendschot TT, Scholl HP, Holz FG. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia. Retina 2008; 28: 808–816.
   PubMed Web of Science ®Google Scholar
• Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol 2006; 124: 450–460.
   PubMedGoogle Scholar
• Wong WT, Forooghian F, Majumdar Z, Bonner RF, Cunningham D, Chew EY. Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry. Am J Ophthalmol 2009; 148: 573–583.
   PubMed Web of Science ®Google Scholar
• Abujamra S, Bonanomi MT, Cresta FB, Machado CG, Pimentel SL, Caramelli CB. Idiopathic juxtafoveolar retinal telangiectasis: clinical pattern in 19 cases. Ophthalmologica 2000; 214: 406–411.
   PubMed Web of Science ®Google Scholar
• Paunescu LA, Ko TH, Duker JS, Chan A, Drexler W, Schuman JS, Fujimoto JG. Idiopathic juxtafoveal retinal telangiectasis: new findings by ultrahigh‐resolution optical coherence tomography. Ophthalmology 2006; 113: 48–57.
   PubMed Web of Science ®Google Scholar
• Tikellis G, Gillies MC, Guymer RH, Mcallister IL, Shaw JE, Wong TY. Retinal vascular caliber and macular telangiectasia type 2. Ophthalmology 2009; 116: 319–323.
   Web of Science ®Google Scholar
• Barthelmes D, Gillies MC, Sutter FK. Quantitative OCT analysis of idiopathic perifoveal telangiectasia. Invest Ophthalmol Vis Sci 2008; 49: 2156–2162.
   PubMed Web of Science ®Google Scholar
• Charbel issa P, Helb HM, Holz FG, Scholl HP. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol 2008; 145: 169–175.
   PubMed Web of Science ®Google Scholar
• Charbel issa P, Helb HM, Rohrschneider K, Holz FG, Scholl HP. Microperimetric assessment of patients with type 2 idiopathic macular telangiectasia. Invest Ophthalmol Vis Sci 2007; 48: 3788–3795.
   PubMed Web of Science ®Google Scholar
• Charbel issa P, Holz FG, Scholl HP. Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Ophthalmology 2007; 114: 1736–1742.
   PubMed Web of Science ®Google Scholar
• Klein R, Blodi BA, Meuer SM, Myers CE, Chew EY, Klein BEK. The prevalence of macular telangiectasia type 2 in the Beaver Dam Eye Study. Am J Ophthalmol 2010; 150: 55–62
   PubMed Web of Science ®Google Scholar
• Charbel issa P, Finger RP, Helb HM, Holz FG, Scholl HP. A new diagnostic approach in patients with type 2 macular telangiectasia: confocal reflectance imaging. Acta Ophthalmol 2008; 86: 464–465.
   PubMed Web of Science ®Google Scholar
• Charbel issa P, Finger RP, Holz FG, Scholl HP. Eighteen‐month follow‐up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Br J Ophthalmol 2008; 92: 941–945.
   PubMed Web of Science ®Google Scholar
• Maruko I, Iida T, Sekiryu T, Fujiwara T. Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry. Br J Ophthalmol 2008; 92: 1488–1491.
   PubMed Web of Science ®Google Scholar
• Surguch V, Gamulescu MA, Gabel VP. Optical coherence tomography findings in idiopathic juxtafoveal retinal telangiectasis. Graefes Arch Clin Exp Ophthalmol 2007; 245: 783–788.
   PubMed Web of Science ®Google Scholar
• Zeimer MB, Padge B, Heimes B, Pauleikhoff D. Idiopathic macular telangiectasia type 2: distribution of macular pigment and functional investigations. Retina 2010; 30: 586–595.
   Web of Science ®Google Scholar
• Davies NP, Morland AB. Macular pigments: their characteristics and putative role. Prog Retin Eye Res 2004; 23: 533–559.
   Web of Science ®Google Scholar
• Trieschmann M, Van kuijk FJ, Alexander R, Hermans P, Luthert P, Bird AC, Pauleikhoff D. Macular pigment in the human retina: histological evaluation of localization and distribution. Eye 2008; 22: 132–137.
   Web of Science ®Google Scholar
• Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol 2006; 124: 1038–1045.
   PubMed Web of Science ®Google Scholar
• Gass JD. Müller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacualr retinoschisis. Arch Ophthalmol 1999; 117: 821–823.
   PubMed Web of Science ®Google Scholar
• Yamada E. Some structural features of the fovea centralis in the human retina. Arch Ophthalmol 1969; 82: 151–159.
   PubMedGoogle Scholar
• Barnaby AM, Hansen RM, Moskowitz A, Fulton AB. Development of scotopic visual thresholds in retinopathy of prematurity. Invest Ophthalmol Vis Sci 2007; 48: 4854–4860.
   Web of Science ®Google Scholar
• Koizumi H, Slakter JS, Spaide RF. Full‐thickness macular hole formation in idiopathic parafoveal telangiectasis. Retina 2007; 27: 473–476.
   PubMed Web of Science ®Google Scholar